| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |